The global analytical standards market size is projected to reach USD 1.7 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 6.3%. Factors such as the increasing adoption of analytical techniques in pesticide monitoring are propelling the growth of the analytical standards market. Additionally, expected patent expiry of major drugs and biomolecules and development of new analytical methods affect the growth of clinical microbiology market. However, limited public awareness related to effective pollution monitoring strategies across developing countries is hampering the growth of this market.
The recent COVID-19 global pandemic has also impacted the analytical standards market.Demand from the main end-users has declined as key regions, and countries have imposed social distancing rules and lockdowns.
This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.
The chromatography segment to witness the highest growth rate in the analytical standards market, by technique, during the forecast period. The chromatography segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the rising use of chromatography across various industries (such as environmental testing, food testing, cosmetics, chemicals, research, forensic, and oil & petrochemical), increasing usage of chromatographic standards in pharmaceutical analysis, and the presence of a large number of mature & emerging suppliers that provide a broad range of chromatographic standards across the globe.
The environmental analytical standards accounted for the largest share of the analytical standards market, by product, in 2019. The environmental analytical standards segment accounted for the largest share of the analytical standards market in 2019.This segment is also estimated to register the highest CAGR during the forecast period.
The large share of this segment can be attributed to factors such as regulatory mandates related to the environment, raising awareness of the importance of a clean environment, degradation of environmental quality, and solid waste generation.
The raw material segment accounted for the largest share of the analytical standards, by methodolgy, in 2019 The raw material segment accounted for the largest market share in 2019. The large share of this segment is attributed to the increasing manufacturing of medicinal & petrochemical products & significant growth in the food & beverage industry, and strong regulatory emphasis on the quality of drugs as well as for food & beverages across the globe.
The Asia Pacific market to grow at the highest CAGR during the forecast period. The analytical standards market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. ncreasing investments by governments in the biotechnology industry, rising outsourcing of clinical trials from developed to emerging Asian nations, strategic expansions of analytical instrument market players in the region, increasing focus on soil testing, food security concerns in India, an increasing number of bioclusters, and high use of analytical technologies in Japan are the major factors driving the growth of the APAC analytical standards market.
Breakdown of supply-side primary interviews: • By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45% • By Designation: C-level: 23%, D-level: 30%, and Others: 47% • By Region: Europe: 30%, North America: 40%, APAC: 22%, Latin America: 6%, and the Middle East & Africa: 2%
The major players operating in the analytical standards market are Merck KGaA (Germany), Agilent Technologies (US), Waters Corporation (US), LGC Standards (UK), and PerkinElmer, Inc. (US). Other prominent players include Restek Corporation (US), SPEX CertiPrep (US), AccuStandard, Inc. (US), Thermo Fisher Scientific, Inc. (US), Mallinckrodt (UK), US Pharmacopeial Convention (US), Cayman Chemical Company (US), RICCA Chemical Company (US), GFS Chemicals, Inc. (US), and Chiron AS (Norway), among others.
Research Coverage This report studies the analytical standards market based on the technique, product, methodology, category, and region.The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders.
Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the analytical standards market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Our reports have been used by over 10K customers, including:
The viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The growth of the market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics...
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing...
Pharmaceutical Robot Market Research Report by Type (Collaborative Pharmaceutical Robots and Traditional Robots), by Application (Drugs Inspection, Laboratory Applications, and Picking & Packaging) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast...
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is expected to grow at a CAGR of 12.6% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However,...
Hypertriglyceridemia Disease - Global Clinical Trials Review H2, 2020 Summary clinical trial report, “Hypertriglyceridemia Disease - Global Clinical Trials Review H2, 2020" provides an overview of Hypertriglyceridemia Clinical trials scenario. This report provides top line data relating to the clinical...
Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Leiomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on...